When injected into humans, he claims, the bioquantines find their way to diseased or damaged cells and help restore them to a healthier state.
The company Dr Paylian founded, Bioquark, is part of a broader project called ReAnima – which is ‘exploring the potential of cutting edge biomedical technology for human neuro-regeneration and neuro-reanimation.’